RedHill Biopharma (RDHL) FCF Margin Growth (1y) (2013 - 2022)
RedHill Biopharma (RDHL) FCF Margin Growth (1y) (2013 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 74.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1,043.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -573.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 734.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 301.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -45,890.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 407.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 610.00 |
| 10 | RedHill Biopharma | 119.32 Mn | 119.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4,839.00 |
| Sep 30, 2022 | 5,373.00 |
| Jun 30, 2022 | -162.00 |
| Mar 31, 2022 | 2,758.00 |
| Dec 31, 2021 | -834.00 |
| Sep 30, 2021 | -4,495.00 |
| Jun 30, 2021 | -1,606.00 |
| Mar 31, 2021 | 92,395.00 |
| Dec 31, 2020 | 81,122.00 |
| Sep 30, 2020 | 59,176.00 |
| Jun 30, 2020 | 58,877.00 |
| Mar 31, 2020 | -54,981.00 |
| Dec 31, 2019 | -26,761.00 |
| Sep 30, 2019 | -25,539.00 |
| Jun 30, 2019 | -30,327.00 |
| Mar 31, 2019 | -4,548.00 |
| Dec 31, 2018 | 10,522.00 |
| Sep 30, 2018 | 31,097.00 |
| Jun 30, 2018 | 163,564.00 |
| Sep 30, 2015 | -37.40 Mn |